The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab. 

Leslee J. Shaw, PhD, and Martha Gulati, MD, are joining forces to discuss how CAD presents in women, advances in imaging technology and much more. 

A new scientific statement from the American Heart Association explores the many ways AI and machine learning are being used to improve care for heart patients.

The new software was also added to the FDA's Tap Pilot program, an honor reserved for “high-quality, safe, effective and innovative medical devices."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

The new collaboration is designed to ensure patients who may face an increased risk of heart disease receive the follow-up care they need.

The company officially launched its Cleerly ISCHEMIA software for delivering noninvasive evaluations of CCTA exams in early 2024. This update provides a closer look at the software from a billing perspective.